Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Switzerland Health Monitor.
Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research
GlobeNewswire, Inc.
·
August 12, 2025
Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global human blood products market size stood at USD 45.82 billion in 2024 and is expected to surge...
Latest Research Offers New Insights into Early Breastfeeding Outcomes, Featured as Open Access in Breastfeeding Medicine through Medela
GlobeNewswire, Inc.
·
August 12, 2025
BAAR, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the publication of the July 2025 Special Issue of Breastfeeding Medicine, titled “Early,...
Global Regenerative Medicine Market Set to Triple, Reaching $49.0 Billion by 2028 | MarketsandMarkets™.
GlobeNewswire, Inc.
·
August 12, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028,...
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
GlobeNewswire, Inc.
·
August 12, 2025
Funding combines equity investment and convertible loan Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs Dr. Thomas Hecht has...
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 12, 2025
Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025 Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks;...
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
GlobeNewswire, Inc.
·
August 12, 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with...
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
GlobeNewswire, Inc.
·
August 12, 2025
Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half of 2028 Expanded ongoing collaboration with...
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
GlobeNewswire, Inc.
·
August 8, 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2025. The full...
Research-Grade Proteins Market to Expand at 15.57% CAGR by 2034
GlobeNewswire, Inc.
·
August 12, 2025
Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global research-grade proteins market size will grow from USD 1.13 billion in 2024 to around USD 4.81 billion...
[Latest] Global Women’s Health Rehabilitation Products Market Size Envisioned at USD 9.68 Billion by 2034, Increasing a CAGR of 6.6% | Healthcare Revolution
GlobeNewswire, Inc.
·
August 7, 2025
NEW YORK, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Women's Health Rehabilitation Products Market By Product (Breast Cancer Care, Chronic Pelvic Pain, Orthopedic Care, Prenatal and...
Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update
GlobeNewswire, Inc.
·
August 12, 2025
Reached full enrolment of Phase 1b study evaluating GT-02287 in Parkinson’s Disease (PD) with or without GBA1 mutations during 2Q 2025, earlier than anticipated Analysis of functional changes and biomarker activity at 90 days will be available...
Periocream: Upcoming Product Launch by bonyf
EIN Presswire
·
August 12, 2025
bonyf invites investors and partners to join this exciting journey via Euronext Paris under the ticker MLBON. bonyf NV (ENX:MLBON) KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, August 12, 2025 /EINPresswire.com/ -- bonyf NV (Ticker: MLBON), a leader in...
Distalmotion Marks Patient Enrollment Milestones in General Surgery and Gynecology Clinical Trials for the DEXTER® Robotic Surgery System
GlobeNewswire, Inc.
·
August 6, 2025
Lausanne, Switzerland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Distalmotion today announced continued momentum in its clinical trial plans to support indication expansion of its DEXTER® Robotic Surgery System in the U.S. This announcement—focused on...
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
GlobeNewswire, Inc.
·
August 6, 2025
Buchanan is former CFO and COO of Silk Road Medical, where he successfully scaled a growth-stage medical device company, leading to an acquisition by Boston Scientific. Buchanan, formerly a venture capitalist with the Vertical Group, is also an...
Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.
GlobeNewswire, Inc.
·
August 12, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at a resilient CAGR of 13.6% from 2024 to 2030, culminating in a...
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
GlobeNewswire, Inc.
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet...
Joint statement on behalf of 29 partners on aid to Gaza and restrictions facing NGOs
Government of Slovenia
·
August 12, 2025
SLOVENIA, August 12 - However, due to restrictive new registration requirements, essential international NGOs may be forced to leave the OPTs imminently which would worsen the humanitarian situation still further. We call on the government of...
Supply Chain Security Market Surges to $5.14 Billion by 2030 - Led by IBM (US), Emerson (US), Oracle (US) | MarketsandMarkets™
GlobeNewswire, Inc.
·
August 12, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the Supply Chain Security Market size is estimated to grow from USD 2.52 Billion in 2024 to USD 5.14 Billion by 2030 at a compound annual growth rate (CAGR) of...
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 12, 2025
Reports second quarter 2025 total revenue of $7.3 million, representing 10% growth compared to the second quarter of 2024. Second quarter 2025 recurring revenue increased 15% compared to the second quarter of 2024. Reports second quarter gross...
IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
GlobeNewswire, Inc.
·
August 11, 2025
Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June...